97 related articles for article (PubMed ID: 31695056)
1. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Zhou S; da Silva SD; Siegel PM; Philip A
Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
[TBL] [Abstract][Full Text] [Related]
3. CD109 identified in circulating proteomics mitigates postoperative recurrence in chronic rhinosinusitis with nasal polyps by suppressing TGF-β1-induced epithelial-mesenchymal transition.
Gao R; Chen Y; Liu H; Ye M; Chu L; Wang T
Int Immunopharmacol; 2024 Mar; 130():111793. PubMed ID: 38442581
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol depletion induces mesenchymal properties in oral squamous cell carcinoma cell line.
do Nascimento RB; Cerqueira PSG; Silva JC; Fontes EK; Dos Santos EA; Dos Santos JN; Nunes FD; Rodrigues MFSD; Paiva KBS; Xavier FCA
J Oral Pathol Med; 2024 Apr; 53(4):246-257. PubMed ID: 38503722
[TBL] [Abstract][Full Text] [Related]
5. GDF-10 Induces an Inhibitory Effect on Epithelial-Mesenchymal Transition of Laryngeal Cancer
Kan X; Ai L; Guan R; Hao J; Sun Y; Xiu W
Curr Pharm Des; 2023; 29(43):3467-3477. PubMed ID: 38163971
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal: LncRNA NEAT2 regulates oral squamous cell carcinoma progression via VEGFB and TGF-β/Smad3 pathway.
Oral Dis; 2024 Apr; 30(3):1733. PubMed ID: 36691734
[No Abstract] [Full Text] [Related]
7. Complex and variable regulation of ΔNp63 and TAp63 by TGFβ has implications for the dynamics of squamous cell epithelial to mesenchymal transition.
Pokorná Z; Tylichová Z; Vojtesek B; Coates PJ
Sci Rep; 2024 Mar; 14(1):7304. PubMed ID: 38538801
[TBL] [Abstract][Full Text] [Related]
8. CD109 drives pro-tumorigenic cell properties in human non-small cell lung cancer through interaction with desmoglein-2.
Lückstädt W; Rathod M; Möbus L; Bub S; Lucius R; Elsner F; Spindler V; Arnold P
Res Sq; 2024 Mar; ():. PubMed ID: 38562713
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic cleavage of the TGFβ co-receptor CD109 changes its conformation, resulting in protease inhibition via activation of its thiol ester, and dissociation from the cell membrane.
Jensen KT; Nielsen NS; Viana Almeida A; Thøgersen IB; Enghild JJ; Harwood SL
FEBS J; 2024 Apr; ():. PubMed ID: 38587194
[TBL] [Abstract][Full Text] [Related]
10. Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.
Ozbay PÖ; Ekinci T; Yiǧit S; Yavuzcan A; Uysal S; Soylu F; Cakalagaoglu F
Onco Targets Ther; 2013; 6():621-7. PubMed ID: 23776335
[TBL] [Abstract][Full Text] [Related]
11. Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease.
Fessel J
Alzheimers Dement (N Y); 2020; 6(1):e12066. PubMed ID: 32995471
[TBL] [Abstract][Full Text] [Related]
12. Tumor edge-to-core transition promotes malignancy in primary-to-recurrent glioblastoma progression in a PLAGL1/CD109-mediated mechanism.
Li C; Cho HJ; Yamashita D; Abdelrashid M; Chen Q; Bastola S; Chagoya G; Elsayed GA; Komarova S; Ozaki S; Ohtsuka Y; Kunieda T; Kornblum HI; Kondo T; Nam DH; Nakano I
Neurooncol Adv; 2020; 2(1):vdaa163. PubMed ID: 33392508
[TBL] [Abstract][Full Text] [Related]
13. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
14. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling.
Lee KY; Kuo TC; Chou CM; Hsu WJ; Lee WC; Dai JZ; Wu SM; Lin CW
Cells; 2020 Dec; 10(1):. PubMed ID: 33375719
[TBL] [Abstract][Full Text] [Related]
16. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
17. Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.
Hagiwara S; Sasaki E; Hasegawa Y; Suzuki H; Nishikawa D; Beppu S; Terada H; Sawabe M; Takahashi M; Hanai N
Cancer Med; 2021 Feb; 10(4):1335-1346. PubMed ID: 33565282
[TBL] [Abstract][Full Text] [Related]
18. CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.
Zhou S; Hassan A; Kungyal T; Tabariès S; Luna JLRG; Siegel PM; Philip A
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954339
[TBL] [Abstract][Full Text] [Related]
19. Application of small extracellular vesicles in the diagnosis and prognosis of nasopharyngeal carcinoma.
Zhang J; Huang D; Lan X; Deng D; Li J; Zhang D; Li Y; Zhong T; Peng S
Front Cell Dev Biol; 2023; 11():1100941. PubMed ID: 36968209
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
